Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Greystoke

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
The British Journal of Surgery|July 22, 2021
Comparison of the effects of FLOT and ECX chemotherapy for oesophagogastric adenocarcinoma on cardiopulmonary reserveJ Chmelo, A W Phillips, A Greystoke, et al.
British Journal of Cancer|April 22, 2010
Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugsK Brookes, J Cummings, A Backen, et al.
British Journal of Cancer|October 21, 2004
Phase I/II study of DHA-paclitaxel in combination with carboplatin in patients with advanced malignant solid tumoursM Harries, A O'Donnell, M Scurr, et al.
British Journal of Cancer|February 25, 2009
Biomarkers of apoptosisT H Ward, J Cummings, E Dean, et al.
British Journal of Cancer|September 22, 2012
Multi-level evidence that circulating CK18 is a biomarker of tumour burden in colorectal cancerA Greystoke, E Dean, M P Saunders, et al.
The British Journal of Surgery|March 31, 2018
Cardiopulmonary fitness before and after neoadjuvant chemotherapy in patients with oesophagogastric cancerM Navidi, A W Phillips, S M Griffin, et al.
Pilot and Feasibility Studies|April 30, 2020
A feasibility study to investigate the utility of a home-based exercise intervention during and after neo-adjuvant chemotherapy for oesophago-gastric cancer-the ChemoFit study protocolJ Chmelo, A W Phillips, A Greystoke, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 11, 2013
Assessment of diurnal changes and confounding factors that affect circulating cell death biomarker levels: a short communicationA Greystoke, G Harris, M Jenkins, et al.
Lung Cancer (Amsterdam, Netherlands)|January 18, 2025
Targeted therapy for older patients with an oncogene driven non-small cell lung cancer: Recommendations from a SIOG expert groupL Decoster, D R Camidge, J A Fletcher, et al.
Psycho-Oncology|November 8, 2025
"The Idea of Being Without It is Frightening". Uncertainty and Psychological Dependency for Patients Using Immuno-, Biological, or Precision Therapies: A Qualitative StudyJ Lecouturier, L Crowe, M C Brown, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
The British Journal of Surgery|July 22, 2021
Comparison of the effects of FLOT and ECX chemotherapy for oesophagogastric adenocarcinoma on cardiopulmonary reserveJ Chmelo, A W Phillips, A Greystoke, et al.
British Journal of Cancer|April 22, 2010
Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugsK Brookes, J Cummings, A Backen, et al.
British Journal of Cancer|October 21, 2004
Phase I/II study of DHA-paclitaxel in combination with carboplatin in patients with advanced malignant solid tumoursM Harries, A O'Donnell, M Scurr, et al.
British Journal of Cancer|February 25, 2009
Biomarkers of apoptosisT H Ward, J Cummings, E Dean, et al.
British Journal of Cancer|September 22, 2012
Multi-level evidence that circulating CK18 is a biomarker of tumour burden in colorectal cancerA Greystoke, E Dean, M P Saunders, et al.
The British Journal of Surgery|March 31, 2018
Cardiopulmonary fitness before and after neoadjuvant chemotherapy in patients with oesophagogastric cancerM Navidi, A W Phillips, S M Griffin, et al.
Pilot and Feasibility Studies|April 30, 2020
A feasibility study to investigate the utility of a home-based exercise intervention during and after neo-adjuvant chemotherapy for oesophago-gastric cancer-the ChemoFit study protocolJ Chmelo, A W Phillips, A Greystoke, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 11, 2013
Assessment of diurnal changes and confounding factors that affect circulating cell death biomarker levels: a short communicationA Greystoke, G Harris, M Jenkins, et al.
Lung Cancer (Amsterdam, Netherlands)|January 18, 2025
Targeted therapy for older patients with an oncogene driven non-small cell lung cancer: Recommendations from a SIOG expert groupL Decoster, D R Camidge, J A Fletcher, et al.
Psycho-Oncology|November 8, 2025
"The Idea of Being Without It is Frightening". Uncertainty and Psychological Dependency for Patients Using Immuno-, Biological, or Precision Therapies: A Qualitative StudyJ Lecouturier, L Crowe, M C Brown, et al.
Pageof 4